---
title: What Actually Happens in a Pre-Submission Meeting with FDA? Part I
description: Is there a way the FDA can give you feedback on your device, before submission? Yes, yes there is! The FDA Pre-Submission is a great service for companies to request feedback from the agency on potential and planned medical devices, biologics, or drug submissions.
image: https://blog.scalehealth.com/hubfs/Hero-073.jpg
---
[](https://www.sierralabs.com/)
- Products
- [Sierra Policies & Procedures](https://www.sierralabs.com/policies-procedures)
- [Sierra Document Automation](https://www.sierralabs.com/document-automation)
- [Sierra Quality Management](https://www.sierralabs.com/quality-management)
- [Sierra GxP Cloud Validation](https://www.sierralabs.com/cloud-validation)
- [Services](https://www.sierralabs.com/services)
- [About Us](https://www.sierralabs.com/about)
- [Partner](https://campaign.sierralabs.com/partner-with-sierra-labs)
- [Blog](https://blog.scalehealth.com)
- [Contact Us](https://www.sierralabs.com/document-automation/#contact-us)
[Contact Us](https://www.sierralabs.com/document-automation/#contact-us)
## Sierra Labs Blog
This is a search field with an auto-suggest feature attached.
- There are no suggestions because the search field is empty.
# What Actually Happens in a Pre-Submission Meeting with FDA? Part I
Posted by [Sierra Labs](https://blog.scalehealth.com/author/sierra-labs) on Oct 3, 2022 12:17:32 AM
- [Tweet](https://twitter.com/share)
Understanding the power of utilizing a pre-submission for your medical device.
Is there a way the FDA can give you feedback on your device, before submission? Yes, yes there is! The FDA Pre-Submission is a great service for companies to request feedback from the agency on potential and planned medical devices, biologics, or drug submissions. We found that it tends not to be utilized enough but there are many reasons why you might want this input before submitting your application!
Let’s explore why this tool was created and how you can utilize it for your own medical solutions!
**Why was the Pre-submission created?**
The Pre-Submission process was created to help companies get ahead of issues before final submission. This can keep your product on track for its development timeline with the foresight of potential problems and discover ways to correct them before the actual submission!
The FDA is always on the lookout for new medical devices to help patients, but they have thousands of applications from companies all over. In order to get their attention and allow you time to study your solution further before making any decisions about whether or not to approve it for use by the public.
**What is a Pre-submission?**
The pre-submission process allows your team to work with the FDA in an informal setting with the goal of ensuring your team is prepared for questions and concerns around the components used, the development process, and the safety of your product. This ensures everyone working together towards common goals has solid data at hand while minimizing risk factors.
FDA provides feedback to sponsors and applicants in the form of a pre-submission meeting or teleconference. This formal written request for information from FDA is called a "Pre-Sub".
FDA is working with a number of device manufacturers to help them bring their products from concept all the way through production. This process has been streamlined so that it only takes one submission type for most devices, which means less time spent waiting and more focus on getting your product off shelves as soon as possible!
**When can you use a Pre-Sub?**
The Pre-Sub is a great way to get FDA’s feedback on specific questions in order for you and your team members to know what they need before going forward with product development or submission preparation.
Your team may take advantage of a pre-submission when considering an investigational or marketing application.
1. Investigational (IND, IDE, HDE, Master Files, Special Protocol Assessment)
2. Marketing (NDA, PMA, BLA, 510k, De Novo)
The information in this document is not applicable to your team when:
1. It pertains specifically and solely to identifying general FDA policies or procedures.
2. Simple clarification questions that can be answered by staff readily
3. Discussion of issues while the submission is under active review
4. Appeal meetings
**When can you submit?**
If your company is considering submitting an application that is classified as investigation or marketing, then pre-submission is the first step. With this submission, you are assured that the FDA will be able to appraise the specifics of the device with ease. The device you are developing could potentially be compliant with the most necessary regulations, but there's always the chance that it won't meet all standards. By providing vital information to the agency, you are giving them a glimpse of the purpose, scope, and timeline of your production process as well as the various steps it's taking to comply with not only a few regulations but up to industry standards.
If your device doesn’t fall within the established risk classifications of the agency making it ambiguous which submission pathway to choose, then you should submit a pre-submission to establish one with the FDA.
[Click here to uncover which regulatory pathway is right for your medical device!](https://blog.sierralabs.com/6-regulatory-pathways-to-bring-your-medical-device-to-market)
Even if you are planning a future study or conducting research that will lead to a future application, you should utilize a pre-submission! The FDA can help you navigate the regulatory process by establishing stepping stones for your research.
**What to include in a Pre-Sub?**
You should submit the following documents and information in your Pre-Submission to the FDA:
1. Cover letter that includes the following information:
2. Pre-Submission package
Other requirements include one eCopy and one hard copy of the application. These should be exact clones of each other. Both should be signed electronically and/or by hand.
**What if I am developing an SaMD and AIaMD?**
It is important to understand the expectations of the FDA before developing a SaMD or AIaMD. Especially for software that includes AI algorithms, the pre-submission can provide valuable insights into the agency’s expectations for these types of solutions.
The FDA can specify how your device will be evaluated such as:
- Parameters for product validation with topics for a test protocol
- Performance benchmarks
- Need for clinical validation/acceptance criteria
- Discussions on methods
- Data points for real-world monitoring and analytics.
## **Simplifying Pre-submission for Your Team**
There are a lot of reasons that companies might be hesitant to use the Pre-Submission program, but it's really not as complicated or time-consuming as you may think.
Sierra Labs has experience working with early-stage medical device companies that do not have clear criteria outlined for their own quality processes. We can simplify this process for your team by helping you implement the necessary well-documented procedures for FDA audits and ISO standards.
Here at Sierra Labs, we help companies solidify their regulatory foundation by creating a unique and tailored quality program to meet organizational objectives with complete transparency and visibility across their entire operation.
**Does Your Team Need Help With Pre-Submission?**
**Click Here for a Free Consultation!**
[](https://hubspot-cta-redirect-na2-prod.s3.amazonaws.com/cta/redirect/5229980/d48da6c0-3334-4efd-a58a-6851421f4bbd)
Ask us anything.
Topics: [ISO 14971](https://blog.scalehealth.com/tag/iso-14971), [Data Security](https://blog.scalehealth.com/tag/data-security), [Data Privacy](https://blog.scalehealth.com/tag/data-privacy), [Data Requirements](https://blog.scalehealth.com/tag/data-requirements), [Data Integrity](https://blog.scalehealth.com/tag/data-integrity), [21 CFR Part 820](https://blog.scalehealth.com/tag/21-cfr-part-820), [Personal Health Information](https://blog.scalehealth.com/tag/personal-health-information), [Health Data](https://blog.scalehealth.com/tag/health-data), [PHI](https://blog.scalehealth.com/tag/phi), [Medical Device Startups](https://blog.scalehealth.com/tag/medical-device-startups), [Scale-ups](https://blog.scalehealth.com/tag/scale-ups), [Cybersecurity](https://blog.scalehealth.com/tag/cybersecurity)
## Featured posts
### Topics
- [FDA (42)](https://blog.scalehealth.com/tag/fda)
- [QMS (31)](https://blog.scalehealth.com/tag/qms)
- [Compliance (28)](https://blog.scalehealth.com/tag/compliance)
- [Medical Device (27)](https://blog.scalehealth.com/tag/medical-device)
- [Medical Device Company (26)](https://blog.scalehealth.com/tag/medical-device-company)
- [SaMD (26)](https://blog.scalehealth.com/tag/samd)
- [Data Security (17)](https://blog.scalehealth.com/tag/data-security)
- [Regulations (17)](https://blog.scalehealth.com/tag/regulations)
- [21 CFR Part 820 (15)](https://blog.scalehealth.com/tag/21-cfr-part-820)
- [Medical Devices (15)](https://blog.scalehealth.com/tag/medical-devices)
- [ISO (14)](https://blog.scalehealth.com/tag/iso)
- [FDA Approval (13)](https://blog.scalehealth.com/tag/fda-approval)
- [Agile (12)](https://blog.scalehealth.com/tag/agile)
- [Data Privacy (12)](https://blog.scalehealth.com/tag/data-privacy)
- [FDA Regulation (12)](https://blog.scalehealth.com/tag/fda-regulation)
- [ISO 13485 (11)](https://blog.scalehealth.com/tag/iso-13485)
- [SaMD Development (11)](https://blog.scalehealth.com/tag/samd-development)
- [CFR Part 820 (10)](https://blog.scalehealth.com/tag/cfr-part-820)
- [Data Requirements (10)](https://blog.scalehealth.com/tag/data-requirements)
- [Document Controls (10)](https://blog.scalehealth.com/tag/document-controls)
- [FDA Pre-Sub (10)](https://blog.scalehealth.com/tag/fda-pre-sub)
- [Health Technology (10)](https://blog.scalehealth.com/tag/health-technology)
- [Regulatory Pathway (10)](https://blog.scalehealth.com/tag/regulatory-pathway)
- [AI (9)](https://blog.scalehealth.com/tag/ai)
- [Documentation (9)](https://blog.scalehealth.com/tag/documentation)
- [GxP Cloud (9)](https://blog.scalehealth.com/tag/gxp-cloud)
- [Quality System Regulation (9)](https://blog.scalehealth.com/tag/quality-system-regulation)
- [Technology (9)](https://blog.scalehealth.com/tag/technology)
- [Validated Cloud (9)](https://blog.scalehealth.com/tag/validated-cloud)
- [risk (9)](https://blog.scalehealth.com/tag/risk)
- [Cloud (8)](https://blog.scalehealth.com/tag/cloud)
- [FDA Audit (8)](https://blog.scalehealth.com/tag/fda-audit)
- [GxP (8)](https://blog.scalehealth.com/tag/gxp)
- [Health Data (8)](https://blog.scalehealth.com/tag/health-data)
- [ISO 13485:2016 (8)](https://blog.scalehealth.com/tag/iso-134852016)
- [ISO 14971 (8)](https://blog.scalehealth.com/tag/iso-14971)
- [Manufacturing (8)](https://blog.scalehealth.com/tag/manufacturing)
- [PHI (8)](https://blog.scalehealth.com/tag/phi)
- [Personal Health Information (8)](https://blog.scalehealth.com/tag/personal-health-information)
- [Conformity (7)](https://blog.scalehealth.com/tag/conformity)
- [Healthcare (7)](https://blog.scalehealth.com/tag/healthcare)
- [Life Science QMS (7)](https://blog.scalehealth.com/tag/life-science-qms)
- [Medical Solutions (7)](https://blog.scalehealth.com/tag/medical-solutions)
- [Product Development (7)](https://blog.scalehealth.com/tag/product-development)
- [Regulatory Strategy (7)](https://blog.scalehealth.com/tag/regulatory-strategy)
- [SaMD QMS (7)](https://blog.scalehealth.com/tag/samd-qms)
- [Software Requirement Specification (7)](https://blog.scalehealth.com/tag/software-requirement-specification)
- [Standards (7)](https://blog.scalehealth.com/tag/standards)
- [21 CFR (6)](https://blog.scalehealth.com/tag/21-cfr)
- [Quality Management System (6)](https://blog.scalehealth.com/tag/quality-management-system)
- [Quality Processes (6)](https://blog.scalehealth.com/tag/quality-processes)
- [Regulatory Roadmap (6)](https://blog.scalehealth.com/tag/regulatory-roadmap)
- [eHealth (6)](https://blog.scalehealth.com/tag/ehealth)
- [21 CFR Part 11 (5)](https://blog.scalehealth.com/tag/21-cfr-part-11)
- [Artificial Intelligence (5)](https://blog.scalehealth.com/tag/artificial-intelligence)
- [CAPA (5)](https://blog.scalehealth.com/tag/capa)
- [COVID19 (5)](https://blog.scalehealth.com/tag/covid19)
- [Design Controls (5)](https://blog.scalehealth.com/tag/design-controls)
- [Digital Health (5)](https://blog.scalehealth.com/tag/digital-health)
- [Health Tech (5)](https://blog.scalehealth.com/tag/health-tech)
- [Jira Cloud (5)](https://blog.scalehealth.com/tag/jira-cloud)
- [Jira QMS (5)](https://blog.scalehealth.com/tag/jira-qms)
- [New Drugs (5)](https://blog.scalehealth.com/tag/new-drugs)
- [QMS healthcare (5)](https://blog.scalehealth.com/tag/qms-healthcare)
- [Sierra QMS (5)](https://blog.scalehealth.com/tag/sierra-qms)
- [training management (5)](https://blog.scalehealth.com/tag/training-management)
- [Automation (4)](https://blog.scalehealth.com/tag/automation)
- [Biopharma (4)](https://blog.scalehealth.com/tag/biopharma)
- [Business Associates (4)](https://blog.scalehealth.com/tag/business-associates)
- [Communication (4)](https://blog.scalehealth.com/tag/communication)
- [Covered Entities (4)](https://blog.scalehealth.com/tag/covered-entities)
- [Data Integrity (4)](https://blog.scalehealth.com/tag/data-integrity)
- [Development Change (4)](https://blog.scalehealth.com/tag/development-change)
- [Drug Approval (4)](https://blog.scalehealth.com/tag/drug-approval)
- [GAMP5 (4)](https://blog.scalehealth.com/tag/gamp5)
- [HIPAA (4)](https://blog.scalehealth.com/tag/hipaa)
- [HIPAA Compliance (4)](https://blog.scalehealth.com/tag/hipaa-compliance)
- [Health Applications (4)](https://blog.scalehealth.com/tag/health-applications)
- [Integrated QMS (4)](https://blog.scalehealth.com/tag/integrated-qms)
- [Medical Device Startups (4)](https://blog.scalehealth.com/tag/medical-device-startups)
- [Pre-Submission (4)](https://blog.scalehealth.com/tag/pre-submission)
- [Product Lifecycle (4)](https://blog.scalehealth.com/tag/product-lifecycle)
- [Quality Roadmap (4)](https://blog.scalehealth.com/tag/quality-roadmap)
- [Recall (4)](https://blog.scalehealth.com/tag/recall)
- [Regulatory Approach (4)](https://blog.scalehealth.com/tag/regulatory-approach)
- [Remote Work (4)](https://blog.scalehealth.com/tag/remote-work)
- [Scale-ups (4)](https://blog.scalehealth.com/tag/scale-ups)
- [Software (4)](https://blog.scalehealth.com/tag/software)
- [Streamline Workflows (4)](https://blog.scalehealth.com/tag/streamline-workflows)
- [document management (4)](https://blog.scalehealth.com/tag/document-management)
- [ePHI (4)](https://blog.scalehealth.com/tag/ephi)
- [510(k) (3)](https://blog.scalehealth.com/tag/510k)
- [COVID-19 Solution (3)](https://blog.scalehealth.com/tag/covid-19-solution)
- [Case Study (3)](https://blog.scalehealth.com/tag/case-study)
- [Compliance Process (3)](https://blog.scalehealth.com/tag/compliance-process)
- [Cybersecurity (3)](https://blog.scalehealth.com/tag/cybersecurity)
- [DTx (3)](https://blog.scalehealth.com/tag/dtx)
- [Design Verification (3)](https://blog.scalehealth.com/tag/design-verification)
- [Document Automation Tools (3)](https://blog.scalehealth.com/tag/document-automation-tools)
- [FDA Standard (3)](https://blog.scalehealth.com/tag/fda-standard)
- [GAMP (3)](https://blog.scalehealth.com/tag/gamp)
- [HIPAA Checklist (3)](https://blog.scalehealth.com/tag/hipaa-checklist)
- [Hardware-based (3)](https://blog.scalehealth.com/tag/hardware-based)
- [IEC 62304 (3)](https://blog.scalehealth.com/tag/iec-62304)
- [ISPE (3)](https://blog.scalehealth.com/tag/ispe)
- [Iterative Process (3)](https://blog.scalehealth.com/tag/iterative-process)
- [Life Science (3)](https://blog.scalehealth.com/tag/life-science)
- [Medical Technology (3)](https://blog.scalehealth.com/tag/medical-technology)
- [Pharma (3)](https://blog.scalehealth.com/tag/pharma)
- [Predicate Device (3)](https://blog.scalehealth.com/tag/predicate-device)
- [Product Requirements Document (3)](https://blog.scalehealth.com/tag/product-requirements-document)
- [QMS for SaMD Startups (3)](https://blog.scalehealth.com/tag/qms-for-samd-startups)
- [Risk Management (3)](https://blog.scalehealth.com/tag/risk-management)
- [SOC (3)](https://blog.scalehealth.com/tag/soc)
- [SOC 2 (3)](https://blog.scalehealth.com/tag/soc-2)
- [SOP (3)](https://blog.scalehealth.com/tag/sop)
- [SaMD Startups (3)](https://blog.scalehealth.com/tag/samd-startups)
- [Software Development (3)](https://blog.scalehealth.com/tag/software-development)
- [Telecare (3)](https://blog.scalehealth.com/tag/telecare)
- [Telehealth (3)](https://blog.scalehealth.com/tag/telehealth)
- [eQMS (3)](https://blog.scalehealth.com/tag/eqms)
- [AWS (2)](https://blog.scalehealth.com/tag/aws)
- [Audit Trails (2)](https://blog.scalehealth.com/tag/audit-trails)
- [CDER (2)](https://blog.scalehealth.com/tag/cder)
- [CE Marking (2)](https://blog.scalehealth.com/tag/ce-marking)
- [CFR (2)](https://blog.scalehealth.com/tag/cfr)
- [Center for Biologics Evaluation and Research (2)](https://blog.scalehealth.com/tag/center-for-biologics-evaluation-and-research)
- [Center for Drug Evaluation and Research (2)](https://blog.scalehealth.com/tag/center-for-drug-evaluation-and-research)
- [Clinical Evaluation (2)](https://blog.scalehealth.com/tag/clinical-evaluation)
- [Corrective Action Preventive Action (2)](https://blog.scalehealth.com/tag/corrective-action-preventive-action)
- [Document Automation (2)](https://blog.scalehealth.com/tag/document-automation)
- [Document Control (2)](https://blog.scalehealth.com/tag/document-control)
- [Documentation Automation (2)](https://blog.scalehealth.com/tag/documentation-automation)
- [Electronic Records (2)](https://blog.scalehealth.com/tag/electronic-records)
- [GMP (2)](https://blog.scalehealth.com/tag/gmp)
- [General Controls (2)](https://blog.scalehealth.com/tag/general-controls)
- [HITRUST (2)](https://blog.scalehealth.com/tag/hitrust)
- [HITRUST CSF (2)](https://blog.scalehealth.com/tag/hitrust-csf)
- [ML (2)](https://blog.scalehealth.com/tag/ml)
- [Machine Learning (2)](https://blog.scalehealth.com/tag/machine-learning)
- [New Draft (2)](https://blog.scalehealth.com/tag/new-draft)
- [Pharmaceutical (2)](https://blog.scalehealth.com/tag/pharmaceutical)
- [Pre-market approval (2)](https://blog.scalehealth.com/tag/pre-market-approval)
- [QS (2)](https://blog.scalehealth.com/tag/qs)
- [Risk Classification (2)](https://blog.scalehealth.com/tag/risk-classification)
- [Risk Managment (2)](https://blog.scalehealth.com/tag/risk-managment)
- [Sierra Policies (2)](https://blog.scalehealth.com/tag/sierra-policies)
- [Sierra Services (2)](https://blog.scalehealth.com/tag/sierra-services)
- [Standard Operating Procedure (2)](https://blog.scalehealth.com/tag/standard-operating-procedure)
- [fda submission (2)](https://blog.scalehealth.com/tag/fda-submission)
- [mHealth Wearables (2)](https://blog.scalehealth.com/tag/mhealth-wearables)
- [rta (2)](https://blog.scalehealth.com/tag/rta)
- [software as medical device (2)](https://blog.scalehealth.com/tag/software-as-medical-device)
- [21 cfr 807 (1)](https://blog.scalehealth.com/tag/21-cfr-807)
- [513G (1)](https://blog.scalehealth.com/tag/513g)
- [AAMI TIR45 (1)](https://blog.scalehealth.com/tag/aami-tir45)
- [AICPA (1)](https://blog.scalehealth.com/tag/aicpa)
- [ANVISA (1)](https://blog.scalehealth.com/tag/anvisa)
- [Agência Nacional de Vigilância Sanitária (1)](https://blog.scalehealth.com/tag/agência-nacional-de-vigilância-sanitária)
- [Amazon Web Services (1)](https://blog.scalehealth.com/tag/amazon-web-services)
- [Analytical Validation (1)](https://blog.scalehealth.com/tag/analytical-validation)
- [Annex 11 (1)](https://blog.scalehealth.com/tag/annex-11)
- [Australian Therapeutic Goods Administration (1)](https://blog.scalehealth.com/tag/australian-therapeutic-goods-administration)
- [BLA (1)](https://blog.scalehealth.com/tag/bla)
- [Backlog (1)](https://blog.scalehealth.com/tag/backlog)
- [Biologic Approval (1)](https://blog.scalehealth.com/tag/biologic-approval)
- [Business Goals (1)](https://blog.scalehealth.com/tag/business-goals)
- [CGMP (1)](https://blog.scalehealth.com/tag/cgmp)
- [Cannabis (1)](https://blog.scalehealth.com/tag/cannabis)
- [Cannabis Compliance (1)](https://blog.scalehealth.com/tag/cannabis-compliance)
- [Change Control (1)](https://blog.scalehealth.com/tag/change-control)
- [Client Reference (1)](https://blog.scalehealth.com/tag/client-reference)
- [Clinical Development (1)](https://blog.scalehealth.com/tag/clinical-development)
- [Clinical Validation (1)](https://blog.scalehealth.com/tag/clinical-validation)
- [Code Reviews (1)](https://blog.scalehealth.com/tag/code-reviews)
- [Conference (1)](https://blog.scalehealth.com/tag/conference)
- [Coronavirus (1)](https://blog.scalehealth.com/tag/coronavirus)
- [Current Good Manufacturing Practice (1)](https://blog.scalehealth.com/tag/current-good-manufacturing-practice)
- [Customer Complaint (1)](https://blog.scalehealth.com/tag/customer-complaint)
- [Data Transfer (1)](https://blog.scalehealth.com/tag/data-transfer)
- [Design Changes (1)](https://blog.scalehealth.com/tag/design-changes)
- [Design History File (1)](https://blog.scalehealth.com/tag/design-history-file)
- [Design Transfer (1)](https://blog.scalehealth.com/tag/design-transfer)
- [Development Team (1)](https://blog.scalehealth.com/tag/development-team)
- [Device Classification (1)](https://blog.scalehealth.com/tag/device-classification)
- [Device Software Functions (1)](https://blog.scalehealth.com/tag/device-software-functions)
- [Document Publishing (1)](https://blog.scalehealth.com/tag/document-publishing)
- [Drug Manufacturing (1)](https://blog.scalehealth.com/tag/drug-manufacturing)
- [EUA (1)](https://blog.scalehealth.com/tag/eua)
- [Electronic Signatures (1)](https://blog.scalehealth.com/tag/electronic-signatures)
- [Emergency Use Authorization (1)](https://blog.scalehealth.com/tag/emergency-use-authorization)
- [Enforcement Discretion (1)](https://blog.scalehealth.com/tag/enforcement-discretion)
- [Engineering (1)](https://blog.scalehealth.com/tag/engineering)
- [Ethos Automated System (1)](https://blog.scalehealth.com/tag/ethos-automated-system)
- [FDA Draft (1)](https://blog.scalehealth.com/tag/fda-draft)
- [HHS (1)](https://blog.scalehealth.com/tag/hhs)
- [Hand Sanitizer (1)](https://blog.scalehealth.com/tag/hand-sanitizer)
- [Hardware Development (1)](https://blog.scalehealth.com/tag/hardware-development)
- [IEC (1)](https://blog.scalehealth.com/tag/iec)
- [IEC 60601 (1)](https://blog.scalehealth.com/tag/iec-60601)
- [IEC 60601:1 (1)](https://blog.scalehealth.com/tag/iec-606011)
- [IEC 62366 (1)](https://blog.scalehealth.com/tag/iec-62366)
- [IFU (1)](https://blog.scalehealth.com/tag/ifu)
- [IND (1)](https://blog.scalehealth.com/tag/ind)
- [ISO 13485: 2003 (1)](https://blog.scalehealth.com/tag/iso-13485-2003)
- [ISO90003:2004 (1)](https://blog.scalehealth.com/tag/iso900032004)
- [Intellectual Property (1)](https://blog.scalehealth.com/tag/intellectual-property)
- [International Electrotechnical Commission (1)](https://blog.scalehealth.com/tag/international-electrotechnical-commission)
- [International Organization for Standardization (1)](https://blog.scalehealth.com/tag/international-organization-for-standardization)
- [Jira Server (1)](https://blog.scalehealth.com/tag/jira-server)
- [Key Terms (1)](https://blog.scalehealth.com/tag/key-terms)
- [Labeling (1)](https://blog.scalehealth.com/tag/labeling)
- [Liability (1)](https://blog.scalehealth.com/tag/liability)
- [MDSAP (1)](https://blog.scalehealth.com/tag/mdsap)
- [METRC (1)](https://blog.scalehealth.com/tag/metrc)
- [MHLW/PMDA (1)](https://blog.scalehealth.com/tag/mhlw-pmda)
- [Management Controls (1)](https://blog.scalehealth.com/tag/management-controls)
- [Masks (1)](https://blog.scalehealth.com/tag/masks)
- [Medical Device Single Audit Program (1)](https://blog.scalehealth.com/tag/medical-device-single-audit-program)
- [Medical Marijuana (1)](https://blog.scalehealth.com/tag/medical-marijuana)
- [Ministry of Health, Labour and Welfare (1)](https://blog.scalehealth.com/tag/ministry-of-health-labour-and-welfare)
- [Myths (1)](https://blog.scalehealth.com/tag/myths)
- [New Approach Directives (1)](https://blog.scalehealth.com/tag/new-approach-directives)
- [New Drug Application (1)](https://blog.scalehealth.com/tag/new-drug-application)
- [Nonconformity (1)](https://blog.scalehealth.com/tag/nonconformity)
- [PCCP (1)](https://blog.scalehealth.com/tag/pccp)
- [PRD (1)](https://blog.scalehealth.com/tag/prd)
- [Pandemic (1)](https://blog.scalehealth.com/tag/pandemic)
- [Part 11 (1)](https://blog.scalehealth.com/tag/part-11)
- [Part 820.30 (1)](https://blog.scalehealth.com/tag/part-820-30)
- [Performance Tests (1)](https://blog.scalehealth.com/tag/performance-tests)
- [Preliminary Screening (1)](https://blog.scalehealth.com/tag/preliminary-screening)
- [Project Deliverables (1)](https://blog.scalehealth.com/tag/project-deliverables)
- [Project Timeline (1)](https://blog.scalehealth.com/tag/project-timeline)
- [QA/RA (1)](https://blog.scalehealth.com/tag/qa-ra)
- [QMSR (1)](https://blog.scalehealth.com/tag/qmsr)
- [Regulatory Options (1)](https://blog.scalehealth.com/tag/regulatory-options)
- [SRS (1)](https://blog.scalehealth.com/tag/srs)
- [SaMD Risk Classification (1)](https://blog.scalehealth.com/tag/samd-risk-classification)
- [SaMD for QMS (1)](https://blog.scalehealth.com/tag/samd-for-qms)
- [SiMD (1)](https://blog.scalehealth.com/tag/simd)
- [Software Architecture (1)](https://blog.scalehealth.com/tag/software-architecture)
- [Sprints (1)](https://blog.scalehealth.com/tag/sprints)
- [Substantial Equivalence (1)](https://blog.scalehealth.com/tag/substantial-equivalence)
- [TGA (1)](https://blog.scalehealth.com/tag/tga)
- [TSC (1)](https://blog.scalehealth.com/tag/tsc)
- [Trust Services Criteria (1)](https://blog.scalehealth.com/tag/trust-services-criteria)
- [Valid Clinical Association (1)](https://blog.scalehealth.com/tag/valid-clinical-association)
- [Validation Testing (1)](https://blog.scalehealth.com/tag/validation-testing)
- [Waterfall Method (1)](https://blog.scalehealth.com/tag/waterfall-method)
- [Webinar (1)](https://blog.scalehealth.com/tag/webinar)
- [Workflow Transitions (1)](https://blog.scalehealth.com/tag/workflow-transitions)
- [abbreviated 510(k) (1)](https://blog.scalehealth.com/tag/abbreviated-510k)
- [administrative evaluation (1)](https://blog.scalehealth.com/tag/administrative-evaluation)
- [medical device quality management system (1)](https://blog.scalehealth.com/tag/medical-device-quality-management-system)
- [paperless quality processes (1)](https://blog.scalehealth.com/tag/paperless-quality-processes)
- [qms Samd (1)](https://blog.scalehealth.com/tag/qms-samd)
- [qms cloud (1)](https://blog.scalehealth.com/tag/qms-cloud)
- [refuse-to-accept (1)](https://blog.scalehealth.com/tag/refuse-to-accept)
- [rta letter (1)](https://blog.scalehealth.com/tag/rta-letter)
- [special 510(k) (1)](https://blog.scalehealth.com/tag/special-510k)
- [traditional 510(k) (1)](https://blog.scalehealth.com/tag/traditional-510k)
See all
### Subscribe Here
- 
- © 2022 Sierra Labs, Inc.
- Contact Us
- [hello@sierralabs.com](mailto:hello@sierralabs.com)
- 3415 S. Sepulveda Blvd.
Suite 1000
Los Angeles, CA 90034
- (310) 437-8010
- Products
- Company
- [About Us](https://www.sierralabs.com/about)